Epiblastin A
Based on 1 publication(s) in Google Scholar
Epiblastin A is an ATP-competitive casein kinase 1 (CK1) inhibitor that inhibits CK1α, CK1δ, and CK1ε. Epiblastin A inhibits the kinase activity of STK10, BRSK1, EEF2K, EGFR, MKNK2, and RIPK2. Epiblastin A inhibits Ki-67 expression, induces Oct4-GFP expression, and enhances the conversion of mouse epiblast stem cells to embryonic stem cells. Epiblastin A selectively reduces the cell viability of colorectal cancer cell lines HCT116, HT29, and DLD1. Epiblastin A can be used in colorectal cancer-related research.
Nur für Forschungszwecke. Wir verkaufen nicht an Patienten.
- Reinheit : 99.44%
- CAS. Nr.: 16470-02-3
- Formel: C12H10ClN7
- Molecular Weight:287.71
-
Speicherung:Powder -20°C, 3 years ; In solvent -80°C, 6 months , -20°C, 1 month
Publications Citing Use of MedChemExpress (MCE) Epiblastin A
MoreAlle EGFR Isoform-spezifische Produkte anzeigen
More
Biologische Aktivität
Beschreibung
|
CK1δ |
CK1α |
CK1ε |
EGFR 8.3 μM (IC50) |
RIPK2 38 μM (IC50) |
Cellular Effect
|
Cell Line
|
Type | Value | Description | References |
|---|---|---|---|---|
| HT-29 | IC50 |
6.8 μM
|
Inhibition of viability of human colorectal carcinoma HT29 cells assessed after 48 hrs treatment by sulforhodamine B (SRB) assay.
Inhibition of viability of human colorectal carcinoma HT29 cells assessed after 48 hrs treatment by sulforhodamine B (SRB) assay.
|
PMC8798578 |
| HCT-116 | IC50 |
5.0 μM
|
Inhibition of viability of human colorectal carcinoma HCT116 cells assessed after 48 hrs treatment by sulforhodamine B (SRB) assay.
Inhibition of viability of human colorectal carcinoma HCT116 cells assessed after 48 hrs treatment by sulforhodamine B (SRB) assay.
|
PMC8798578 |
| DLD-1 | IC50 |
3.2 μM
|
Inhibition of viability of human colorectal carcinoma DLD1 cells assessed after 48 hrs treatment by sulforhodamine B (SRB) assay.
Inhibition of viability of human colorectal carcinoma DLD1 cells assessed after 48 hrs treatment by sulforhodamine B (SRB) assay.
|
PMC8798578 |
In Vitro
Epiblastin A (0.5-25 μM; 48 h) dose-dependently inhibits the viability of HT29, HCT116, and DLD1 colorectal cancer cell lines with IC50 values of 6.8, 5.0, and 3.2 μM, respectively, and exhibits no cytotoxicity against normal FHC colon cells[1].
Epiblastin A promotes the late-stage reprogramming of mouse epiblast stem cells (mEpiSCs) to mouse embryonic stem cells (mESCs), and it inhibits the CK1 family during this late-stage reprogramming process[2].
Epiblastin A is a potent inhibitor of CK1α, CK1δ, and CK1ε, with the strongest inhibitory potency against CK1δ; it also inhibits STK10 kinase activity[3].
MedChemExpress (MCE) has not independently confirmed the accuracy of these methods. They are for reference only. Further protocols information, click here.
-
Cell Line:HT29, HCT116, DLD1, FHC
-
Concentration:0.5, 1, 2.5, 5, 10, 25 μM
-
Incubation Time:48 h
-
Result:Suppressed the viability of cells.
Exhibited no apparent effect on the viability of FHC normal colonic cells.
Achieved 48 h IC50 values of 6.8 μM for HT29, 5.0 μM for HCT116, and 3.2 μM for DLD1 cells.
In Vivo
MedChemExpress (MCE) has not independently confirmed the accuracy of these methods. They are for reference only.
-
Animal Model:NOD.CB17-Prkdcscid/NcrCrl (NOD/SCID) (5-6 weeks old, Forty thousand DLD1 cells)[1]
-
Dosage:5 mg/kg
-
Administration:i.p.; every 72 h; 45 days
-
Result:Resulted in tumor sizes comparable to those in mice treated with 5 mg/kg Cetuximab (HY-P9905), with no apparently significant effect on mouse body weights.
Resulted in significantly smaller tumors than in vehicle-treated mice at the same time-point. Markedly reduced tumor growth compared to the vehicle-treated control group, with no apparent effect on mouse body weights.
Caused a 2.18-fold reduction in median tumor weight over the time-course of the animal study.
Profoundly suppressed the enhanced expression of CK1α (1.42-fold).
Chemical Information
-
CAS. Nr. 16470-02-3
-
Appearance Solid
-
Molecular Weight 287.71
-
Formel C12H10ClN7
-
Color Light yellow to green yellow
-
SMILES
NC1=NC(N)=C2N=C(C(N)=NC2=N1)C3=CC=CC(Cl)=C3
-
Versand
Room temperature in continental US; may vary elsewhere.
-
Speicherung
Powder -20°C 3 years In solvent -80°C 6 months -20°C 1 month
Publications (1)
-
Journal Impact Factor
-
Most Recent
-
J Clin Invest
Molecular glue degrader function of SPOP enhances STING-dependent immunotherapy efficacy in melanoma models. [Abstract]2025 Oct 28:e191772. PMID: 41148213
Lösungsmittel & Löslichkeit
In Vitro:
DMSO : 4.55 mg/mL (15.81 mM; ultrasonic and warming and heat to 60°C; Hygroscopic DMSO has a significant impact on the solubility of product, please use newly opened DMSO)
Please refer to the solubility information to select the appropriate solvent. Once prepared, please aliquot and store the solution to prevent product inactivation from repeated freeze-thaw cycles.
Storage method and period of stock solution: -80°C, 6 months; -20°C, 1 month. When stored at -80°C, please use it within 6 months. When stored at -20°C, please use it within 1 month.
Please refer to the solubility information to select the appropriate solvent. Once prepared, please aliquot and store the solution to prevent product inactivation from repeated freeze-thaw cycles.
Storage method and period of stock solution: -80°C, 6 months; -20°C, 1 month. When stored at -80°C, please use it within 6 months. When stored at -20°C, please use it within 1 month.
Konzentration (Stammlösung) × Volumen (Stammlösung) = Konzentration (Ziellösung) × Volumen (Ziellösung)
Protokoll
-
Kinase activity and phosphorylation assays
Kinase activity assays measure the ability of kinases to transfer phosphate groups from ATP to specific substrates, while phosphorylation assays detect the presence and levels of phosphorylated proteins. Common methods include radiolabeled ATP incorporation (e. g. ,), ADP release detection via bioluminescence (e. g. ,[3]), enzyme-linked immunosorbent assays (ELISA) for phospho-specific epitopes (e. g. ,[6]), and microtiter-based formats for high-throughput screening (e. g. ,[8]). The ADP-Glo assay quantifies kinase activity by measuring ADP produced during phosphorylation using a luciferase-based system. Radiometric assays involve autoradiography or scintillation counting after incorporation of 32P-labeled ATP into substrate proteins. ELISA-based approaches rely on phospho-specific antibodies to detect activated kinases in cell lysates or purified samples.
-
RNA extraction experimental
By lysing cells, releasing RNA, and removing impurities such as proteins and DNA, high-purity RNA products are finally obtained. The commonly used traditional method is the guanidine isothiocyanate/phenol/chloroform method (Trizol), which is suitable for a variety of animal materials including animal tissues, microorganisms, cultured cells, etc., and most plant materials.
-
Ki-67 Immunostaining Proliferation Assay
Ki-67 immunostaining measures the growth fraction of a cell population by detecting Ki-67, a nuclear antigen present in proliferating cells and absent in quiescent G0 cells. The readout is the percentage of Ki-67-positive nuclei among total counted cells, commonly called the Ki-67 labeling index or proliferation index.
-
Cell Cytotoxicity Assay
Cytotoxicity assays are usually based on the assessment of cell membrane damage, which can also be indirectly detected by measuring cell viability. Detection methods include MTT assay, CKK-8 assay, LDH assay and ATP assay, etc.
-
Mammalian live/dead viability and cytotoxicity staining
Live/dead viability and cytotoxicity staining assays are based on the simultaneous detection of intracellular esterase activity in metabolically active (viable) cells and membrane integrity loss in non-viable cells. In commonly used dual-staining approaches, membrane-permeant fluorogenic substrates are converted by intracellular esterases into fluorescent products in live cells, while impermeant DNA-binding dyes selectively enter cells with compromised plasma membranes and label nucleic acids in dead or dying cells, enabling discrimination between viable and non-viable populations by fluorescence microscopy or flow cytometry.
-
CCK-8/WST-8 Cell Proliferation Assay
The CCK-8/WST-8 assay is based on the reduction of the water-soluble tetrazolium salt WST-8 to a water-soluble formazan product by cellular dehydrogenases in metabolically active cells, where the generated formazan amount is proportional to the number of living cells and is quantified by measuring absorbance in the visible range, providing a colorimetric readout for cell viability and proliferation assessment. This class of tetrazolium-based assays improves upon earlier MTT-based systems by producing a water-soluble formazan, eliminating the need for organic solubilization steps and enabling direct spectrophotometric measurement in culture medium.
-
Protocol for Kinase activity and phosphorylation assays
Kinase activity assays measure transfer of phosphate from ATP to a protein or peptide substrate, generating phosphorylated substrate, ADP, or incorporated radiolabeled phosphate as the readout; phosphorylation assays measure site-specific phosphorylation in cells or tissues as a proxy for kinase-pathway activation, inhibition, or substrate regulation. Phosphorylation can be detected by phospho-specific Western blot, immunoprecipitation kinase assay, phospho-immunofluorescence, phospho-flow cytometry, luminescent ADP detection, radiolabeled ATP incorporation, or reporter-based pathway assays, and these readouts can be applied to cancer cells, primary neurons, mouse tumors, organoids, inflammatory macrophages, ferroptosis studies, and mitophagy studies when the kinase target is biologically relevant.
-
MTT Cell Proliferation Assay
The MTT assay is a colorimetric endpoint assay for estimating viable cell number, cell growth, cytotoxicity, or cell activation in cultured mammalian cells. Living cells reduce the yellow tetrazolium salt MTT into purple/blue formazan, while dead cells do not generate the same signal; the resulting color can be quantified with a multiwell spectrophotometer. MTT reduction is commonly interpreted as a readout of metabolic activity that often correlates with viable cell number, but it should not be treated as a direct cell-counting method unless the assay is optimized for the cell type and experimental condition. Studies show that MTT reduction can involve mitochondrial and non-mitochondrial reducing systems, and formazan may accumulate in intracellular lipid droplets rather than simply marking mitochondria.
-
Cell Viability Determination by MTT Colorimetric Assay
The following protocol uses the MTT colorimetric assay as a classic literature-established method for assessing cell viability/metabolic activity in cultured mammalian cells. MTT[3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide] is reduced by metabolically active cells to a colored formazan product; the amount of formazan is quantified spectrophotometrically and provides an indirect measure of metabolically active viable cells. Importantly, MTT reduction reflects cellular oxidoreductase/metabolic activity rather than an absolute direct count of living cells, so changes in cellular metabolism can alter the signal independently of cell number.
Reinheit & Dokumentation
-
Data Sheet (287 KB)
-
SDS (251 KB)
- English - EN (251 KB)
- Français - FR (251 KB)
- Deutsch - DE (251 KB)
- Norwegian - NO (251 KB)
- Español - ES (251 KB)
- Swedish - SV (251 KB)
- Italian - IT (251 KB)
- Korean - KR (251 KB)
- Portuguese - PT (251 KB)
-
Handling Instructions (2659 KB)
Verweise
Complete Stock Solution Preparation Table
Please refer to the solubility information to select the appropriate solvent. Once prepared, please aliquot and store the solution to prevent product inactivation from repeated freeze-thaw cycles.
Storage method and period of stock solution: -80°C, 6 months; -20°C, 1 month. When stored at -80°C, please use it within 6 months. When stored at -20°C, please use it within 1 month.
| Optional Solvent | Concentration Solvent Mass | 1 mg | 5 mg | 10 mg | 25 mg |
|---|---|---|---|---|---|
| DMSO | 1 mM | 3.4757 mL | 17.3786 mL | 34.7572 mL | 86.8931 mL |
| 5 mM | 0.6951 mL | 3.4757 mL | 6.9514 mL | 17.3786 mL | |
| 10 mM | 0.3476 mL | 1.7379 mL | 3.4757 mL | 8.6893 mL | |
| 15 mM | 0.2317 mL | 1.1586 mL | 2.3171 mL | 5.7929 mL |